Lupin gets USFDA nod for generic oral contraceptive pill 

The company has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drospirenone Tablets in 4 mg strength, said the drug maker.

published on : 4th November 2022

Zydus Lifesciences gets USFDA nod to market generic acne drug

A combination of Adapalene (a retinoid) and Benzoyl Peroxide (an antibiotic and skin-peeling agent), the gel is used to decrease the number and severity of acne pimples.

published on : 7th June 2022

Aurobindo, Sun Pharma recall products in US market 

The US health regulator noted that US-based Sun Pharmaceutical Industries Inc is recalling 73,030 boxes of Cequa (cyclosporine ophthalmic solution) for being a "Subpotent Drug".

published on : 25th April 2022

Alembic Pharmaceuticals' joint venture gets USFDA final nod for anti-fungal drug

The approval by the USFDA is for the abbreviated new drug application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment of strength 100,000 units/gram.

published on : 8th March 2022